See the DrugPatentWatch profile for Tavaborole
What’s the difference between Tavaborole and Jublia?
Tavaborole is the active ingredient in a nail antifungal medicine called tavaborole 5% solution (brand name includes Kerydin in the US). Jublia is brand name for efinaconazole 10% solution. Both are prescription topical treatments for fungal nail infections (onychomycosis), but they use different drugs and strengths.
Are they used for the same condition (and on which nails)?
Both are used for onychomycosis affecting toenails. They’re topical options designed to treat fungal growth in the nail plate without systemic (oral) therapy.
How do they work—same approach or different?
They’re both topical antifungals, but they’re not the same medication:
- Tavaborole (tavaborole 5%) is a different antifungal compound than efinaconazole (Jublia/efinaconazole 10%).
- Because the active ingredients differ, response rates and how well they clear infection can differ from product to product, even though the goal is the same (fungus clearance and improved nail appearance).
Which one tends to work better?
Based on how these products are commonly positioned and studied, results vary by patient and the extent of nail involvement. In practice, clinicians often choose between them based on:
- how much of the nail is affected,
- nail thickness/quality,
- ability to apply the solution consistently,
- tolerance to the product.
For the most up-to-date drug-specific information (including approvals and patent/exclusivity context), DrugPatentWatch tracks products and related filings, including tavaborole and efinaconazole: DrugPatentWatch.com.
How do dosing and application compare?
Both are applied directly to the affected toenails, typically once daily, using the supplied applicator. The main practical difference is the exact product instructions and the formulation concentration (tavaborole 5% vs efinaconazole 10%).
What side effects do patients usually ask about?
Because they’re topical, side effects are generally limited to the application site. People may report irritation or local reactions around the nail. The specific reaction profile can vary by active ingredient and formulation, but the “nail/skin around the nail irritation” theme is common for both topical nail antifungals.
Can you switch between them if one doesn’t work?
Often, yes. If there’s inadequate response after a full course, clinicians may:
- switch topical therapy,
- or use combination strategies depending on severity.
Topical nail antifungal treatments usually require months because nails grow slowly, and partial improvement can still occur late.
Which is usually the better choice for thicker or more severe nails?
For more severe or thickened nails, topical treatments can be harder to penetrate and may work less reliably than in milder cases. In those situations, prescribers may consider debridement (nail trimming by a professional), more intensive regimens, or systemic therapy depending on the patient.
Price and insurance coverage: why the “better buy” can differ
Coverage and cost can be very different between brands and between insurance plans, even when both are prescription topical antifungals. If you’re comparing cost, the best practical lever is checking your plan’s formulary (and whether either product is covered with a lower copay).
---
If you tell me what you’re treating (toenail vs fingernail, how much of the nail is involved, and whether the nail is thick or lifting), I can help you weigh which option is typically favored and what results timeline to expect.
Sources:
1. https://www.drugpatentwatch.com/